Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Nucleic Acid-based Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
BioMedica (Oxford BioMedica)
Caperna
EGEN (Expression Genetics)
Transgene
Phylogica
Imugene
Copernicus Therapeutics Inc
Benitec Biopharma
Wave Life Sciences Ltd
By Type:
Single-Stranded DNA/RNA
Double-Stranded DNA
By Application:
Specialty Clinics
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Nucleic Acid-based Drugs Market Overview 2018-2029
-
1.1 China Nucleic Acid-based Drugs Industry Development Overview
-
1.2 China Nucleic Acid-based Drugs Industry Development History
-
1.3 China Nucleic Acid-based Drugs Industry Market Size (2018-2029)
-
1.4 China Nucleic Acid-based Drugs Market Analysis by Type from Production Side
-
1.4.1 China Nucleic Acid-based Drugs Production Volume, Production Value and Growth Rate of Single-Stranded DNA/RNA (2018-2029)
-
1.4.2 China Nucleic Acid-based Drugs Production Volume, Production Value and Growth Rate of Double-Stranded DNA (2018-2029)
-
1.5 China Nucleic Acid-based Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Nucleic Acid-based Drugs Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
1.5.2 China Nucleic Acid-based Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Nucleic Acid-based Drugs Market Analysis by Region
-
1.6.1 North China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Nucleic Acid-based Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Nucleic Acid-based Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Nucleic Acid-based Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Nucleic Acid-based Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Nucleic Acid-based Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Nucleic Acid-based Drugs Industry Development
Chapter 3 Nucleic Acid-based DrugsIndustry Chain Analysis
-
3.1 Nucleic Acid-based Drugs Industry Chain
-
3.2 Nucleic Acid-based Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Nucleic Acid-based Drugs Market
-
3.3 Nucleic Acid-based Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Nucleic Acid-based Drugs Market
Chapter 4 China Nucleic Acid-based Drugs Market, by Type
-
4.1 China Nucleic Acid-based Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Nucleic Acid-based Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Nucleic Acid-based Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Nucleic Acid-based Drugs Production Volume and Growth Rate of Single-Stranded DNA/RNA
-
4.5.2 China Nucleic Acid-based Drugs Production Volume and Growth Rate of Double-Stranded DNA
Chapter 5 China Nucleic Acid-based Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Nucleic Acid-based Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Nucleic Acid-based Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Nucleic Acid-based Drugs Market Size and Growth Rate of Specialty Clinics
-
5.5.2 China Nucleic Acid-based Drugs Market Size and Growth Rate of Hospitals
Chapter 6 China Nucleic Acid-based Drugs Market, by Region
-
6.1 China Nucleic Acid-based Drugs Production Volume and Production Value, by Region
-
6.2 China Nucleic Acid-based Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Nucleic Acid-based Drugs Market Analysis
-
7.1 North China Nucleic Acid-based Drugs Market, by Type
-
7.2 North China Nucleic Acid-based Drugs Market, by Application
Chapter 8 Central China Nucleic Acid-based Drugs Market Analysis
-
8.1 Central China Nucleic Acid-based Drugs Market, by Type
-
8.2 Central China Nucleic Acid-based Drugs Market, by Application
Chapter 9 South China Nucleic Acid-based Drugs Market Analysis
-
9.1 South China Nucleic Acid-based Drugs Market, by Type
-
9.2 South China Nucleic Acid-based Drugs Market, by Application
Chapter 10 East China Nucleic Acid-based Drugs Market Analysis
-
10.1 East China Nucleic Acid-based Drugs Market, by Type
-
10.2 East China Nucleic Acid-based Drugs Market, by Application
Chapter 11 Northeast China Nucleic Acid-based Drugs Market Analysis
-
11.1 Northeast China Nucleic Acid-based Drugs Market, by Type
-
11.2 Northeast China Nucleic Acid-based Drugs Market, by Application
Chapter 12 Southwest China Nucleic Acid-based Drugs Market Analysis
-
12.1 Southwest China Nucleic Acid-based Drugs Market, by Type
-
12.2 Southwest China Nucleic Acid-based Drugs Market, by Application
Chapter 13 Northwest China Nucleic Acid-based Drugs Market Analysis
-
13.1 Northwest China Nucleic Acid-based Drugs Market, by Type
-
13.2 Northwest China Nucleic Acid-based Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 BioMedica (Oxford BioMedica)
-
14.1.1 BioMedica (Oxford BioMedica) Company Profile
-
14.1.2 BioMedica (Oxford BioMedica) Nucleic Acid-based Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Caperna
-
14.2.1 Caperna Company Profile
-
14.2.2 Caperna Nucleic Acid-based Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 EGEN (Expression Genetics)
-
14.3.1 EGEN (Expression Genetics) Company Profile
-
14.3.2 EGEN (Expression Genetics) Nucleic Acid-based Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Transgene
-
14.4.1 Transgene Company Profile
-
14.4.2 Transgene Nucleic Acid-based Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Phylogica
-
14.5.1 Phylogica Company Profile
-
14.5.2 Phylogica Nucleic Acid-based Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Imugene
-
14.6.1 Imugene Company Profile
-
14.6.2 Imugene Nucleic Acid-based Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Copernicus Therapeutics Inc
-
14.7.1 Copernicus Therapeutics Inc Company Profile
-
14.7.2 Copernicus Therapeutics Inc Nucleic Acid-based Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Benitec Biopharma
-
14.8.1 Benitec Biopharma Company Profile
-
14.8.2 Benitec Biopharma Nucleic Acid-based Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Wave Life Sciences Ltd
-
14.9.1 Wave Life Sciences Ltd Company Profile
-
14.9.2 Wave Life Sciences Ltd Nucleic Acid-based Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Nucleic Acid-based Drugs Industry Research Conclusions
-
15.2 Nucleic Acid-based Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Nucleic Acid-based Drugs Industry Market Size (2018-2029)
-
Figure China Nucleic Acid-based Drugs Production Volume, Production Value and Growth Rate of Single-Stranded DNA/RNA (2018-2029)
-
Figure China Nucleic Acid-based Drugs Production Volume, Production Value and Growth Rate of Double-Stranded DNA (2018-2029)
-
Figure China Nucleic Acid-based Drugs Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
Figure China Nucleic Acid-based Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Nucleic Acid-based Drugs Market Size and Growth Rate from 2018-2029
-
Figure Nucleic Acid-based Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Nucleic Acid-based Drugs Market Share by Type in 2018
-
Figure China Nucleic Acid-based Drugs Market Share by Type in 2023
-
Figure China Nucleic Acid-based Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Nucleic Acid-based Drugs Production Volume and Growth Rate of Single-Stranded DNA/RNA (2018-2023)
-
Figure China Nucleic Acid-based Drugs Production Volume and Growth Rate of Double-Stranded DNA (2018-2023)
-
Figure China Nucleic Acid-based Drugs Market Share by Application in 2018
-
Figure China Nucleic Acid-based Drugs Market Share by Application in 2023
-
Figure China Nucleic Acid-based Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Nucleic Acid-based Drugs Market Size and Growth Rate of Specialty Clinics (2018-2023)
-
Figure China Nucleic Acid-based Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Nucleic Acid-based Drugs Production Volume by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Production Volume Share by Region (2018-2023)
-
Figure China Nucleic Acid-based Drugs Production Volume Share by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Production Value by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Production Value Share by Region (2018-2023)
-
Figure China Nucleic Acid-based Drugs Production Value Share by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Sales Volume by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Nucleic Acid-based Drugs Sales Volume Share by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Sales Value by Region (2018-2023)
-
Table China Nucleic Acid-based Drugs Sales Value Share by Region (2018-2023)
-
Figure China Nucleic Acid-based Drugs Sales Value Share by Region (2018-2023)
-
Table North China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table North China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table North China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table North China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table Central China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table Central China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table South China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table South China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table South China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table East China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table East China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table East China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Nucleic Acid-based Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Nucleic Acid-based Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Nucleic Acid-based Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Nucleic Acid-based Drugs Sales Volume Share by Application (2018-2023)
-
Table BioMedica (Oxford BioMedica) Company Profile
-
Table BioMedica (Oxford BioMedica) Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Caperna Company Profile
-
Table Caperna Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table EGEN (Expression Genetics) Company Profile
-
Table EGEN (Expression Genetics) Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Transgene Company Profile
-
Table Transgene Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Phylogica Company Profile
-
Table Phylogica Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Imugene Company Profile
-
Table Imugene Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Copernicus Therapeutics Inc Company Profile
-
Table Copernicus Therapeutics Inc Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Benitec Biopharma Company Profile
-
Table Benitec Biopharma Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
Table Wave Life Sciences Ltd Company Profile
-
Table Wave Life Sciences Ltd Nucleic Acid-based Drugs Revenue, Price and Gross (2018-2023)
-
